These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers. Umemura K; Ikeda Y; Kondo K; Nakashima M; Naganuma H; Hisaoka M; Nishino H; Tajima M Antimicrob Agents Chemother; 1997 Dec; 41(12):2664-9. PubMed ID: 9420036 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074 [TBL] [Abstract][Full Text] [Related]
26. Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects. Gajjar DA; Bello A; Ge Z; Christopher L; Grasela DM Antimicrob Agents Chemother; 2003 Jul; 47(7):2256-63. PubMed ID: 12821477 [TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients. Cundy KC; Barditch-Crovo P; Petty BG; Ruby A; Redpath M; Jaffe HS; Lietman PS Antimicrob Agents Chemother; 1999 Feb; 43(2):271-7. PubMed ID: 9925517 [TBL] [Abstract][Full Text] [Related]
28. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. Pue MA; Pratt SK; Fairless AJ; Fowles S; Laroche J; Georgiou P; Prince W J Antimicrob Chemother; 1994 Jan; 33(1):119-27. PubMed ID: 8157552 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Schneider M; Thomas V; Boisrame B; Deleforge J J Vet Pharmacol Ther; 1996 Feb; 19(1):56-61. PubMed ID: 8992027 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers. Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768 [TBL] [Abstract][Full Text] [Related]
32. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Ritz M; Lode H; Fassbender M; Borner K; Koeppe P; Nord CE Antimicrob Agents Chemother; 1994 Mar; 38(3):455-9. PubMed ID: 8203837 [TBL] [Abstract][Full Text] [Related]
33. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease. Hey JA; Yu JY; Versavel M; Abushakra S; Kocis P; Power A; Kaplan PL; Amedio J; Tolar M Clin Pharmacokinet; 2018 Mar; 57(3):315-333. PubMed ID: 29063518 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg. Montay G; Bruno R; Vergniol JC; Ebmeier M; Le Roux Y; Guimart C; Frydman A; Chassard D; Thebault JJ J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, safety and tolerability of the orally administered receptor antagonist of cysteinyl-leukotrienes BAY x 7195 in single-dose escalation studies. Heinig R; Schaefer HG; Wensing G; Kuhlmann J Int J Clin Pharmacol Ther; 1995 Oct; 33(10):573-9. PubMed ID: 8574510 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry. Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913 [TBL] [Abstract][Full Text] [Related]
37. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing. Mant TG Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066 [TBL] [Abstract][Full Text] [Related]
38. Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects. Filer CW; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE; Prince WT; Ramji JV Xenobiotica; 1994 Apr; 24(4):357-68. PubMed ID: 8059539 [TBL] [Abstract][Full Text] [Related]
39. Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers. Schmitt-Hoffmann A; Roos B; Heep M; Schleimer M; Weidekamm E; Brown T; Roehrle M; Beglinger C Antimicrob Agents Chemother; 2006 Jan; 50(1):279-85. PubMed ID: 16377698 [TBL] [Abstract][Full Text] [Related]
40. Dose-proportionality of eltoprazine. Pharmacokinetics of single oral doses in healthy subjects. de Vries MH; de Koning P; Floot HL; Grahnén A; Eckernäs SA; Raghoebar M; Dahlström B; Ekman L Eur J Clin Pharmacol; 1991; 41(5):485-8. PubMed ID: 1761079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]